- recruitingPHASE4
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
This study looks at the best way to treat small blood clots in the lungs (isolated subsegmental pulmonary embolism) in people at low risk. It compares watching carefully without treatment to giving blood-thinning medicine to reduce bleeding risks.
Belgium · Canada · France - authorisedHuman Pharmacology (Phase I)- First administration to humans
Adoptive TIL therapy in combination with chemoimmunotherapy in advanced NSCLC patients
This early-stage study is looking at a new way to treat lung cancer called adoptive TIL therapy. It combines this new treatment with standard chemotherapy and immunotherapy. The goal is to see if it's safe and how it works in adults with advanced non-small cell lung cancer.
Netherlands - ongoing, recruitingTherapeutic exploratory (Phase II)
A randomized Phase 2, double-blind, placebo-controlled, parallel-group, 2-arm study to assess the efficacy, safety, and tolerability of subcutaneous lunsekimig in adult participants with chronic rhinosinusitis with nasal polyps (CRSwNP)
This study looks at a new medicine called lunsekimig for adults with long-term stuffy nose and growths called nasal polyps. It compares lunsekimig to a dummy medicine to see if it makes symptoms better and if it's safe.
Bulgaria · Poland · Belgium